---
figid: PMC9878249__MEF2-1-0-g007
pmcid: PMC9878249
image_filename: MEF2-1-0-g007.jpg
figure_link: /pmc/articles/PMC9878249/figure/mef229-fig-0006/
number: Figure 6
figure_title: ''
caption: The interaction of SARS‐CoV‐2 proteins on RIG‐I‐MAVS pathway. SARS‐CoV‐2
  RNA activates the RIG‐I‐MAVS‐dependent IFN signaling pathway. During SARS‐CoV‐2
  infection, various proteins of SARS‐CoV‐2 can act differently on RIG‐I‐MAVS to antagonize
  the antiviral type I IFN response. IFN, interferon; MAVS, mitochondrial antiviral
  signaling; RIG‐I, retinoic acid‐inducible gene I.
article_title: 'SARS‐CoV‐2 modulation of RIG‐I‐MAVS signaling: Potential mechanisms
  of impairment on host antiviral immunity and therapeutic approaches.'
citation: Mingming Wang, et al. 2022 Sep;1(2):e29.
year: '2022'

doi: 10.1002/mef2.29
journal_title: MedComm – Future Medicine
journal_nlm_ta: ''
publisher_name: John Wiley and Sons Inc.

keywords:
- antiviral immunity
- RIG‐I‐MAVS signaling
- SARS‐CoV‐2
- therapeutic approaches

---
